Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias
- PMID: 26174192
- DOI: 10.1016/j.rmed.2015.06.003
Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias
Abstract
Introduction: Accurate diagnosis of idiopathic pulmonary fibrosis (IPF) has important therapeutic and prognostic implications and would be greatly aided by reliable diagnostic biomarkers as IPF has sometimes overlapping features with other interstitial lung diseases (ILD).
Objectives: To explore the value of serum metalloproteinases (MMP) 1 and 7 levels in the differential diagnosis of IPF with other ILD.
Methods: MMP-1/7 serum levels were measured using Luminex xMAP technology in 139 patients- 47 IPF, 36 non-IPF Usual Interstitial Pneumonia (UIP), 14 idiopathic Nonspecific Interstitial Pneumonia (iNSIP), 29 secondary NSIP (secNSIP), 13 stage IV sarcoidosis- and 20 healthy controls, and compared using the Mann-Whitney U test.
Results: MMP-1 was significantly higher in IPF than non-IPF UIP (P = .042) and sarcoidosis (P = .027). MMP-7 was significantly higher in IPF than controls (P < .001), non-IPF UIP (P = .003), secNSIP (P < .001), and sarcoidosis (P < .001). The Area Under the Curve for IPF versus other ILD was 0.63 (95%CI, 0.53-0.73) for MMP-1, 0.73 (95%CI, 0.65-0.81) for MMP-7, and 0.74 (95%CI, 0.66-0.82) for MMP-1/MMP-7 combined. Sensitivity and specificity for MMP-7 cutoff = 3.91 ng/mL was 72.3% and 66.3%, respectively, Positive Predictive Values = 52.3% and Negative Predictive Values = 82.4%.
Conclusions: MMP-1 and particularly MMP-7 serum levels were significantly higher in IPF than in non-IPF UIP, the main entity in differential diagnosis. The value of these biomarkers as additional tools in a multidisciplinary approach to IPF diagnosis needs to be considered and further explored.
Keywords: Idiopathic interstitial pneumonias; Idiopathic pulmonary fibrosis; Metalloproteinase 1; Metalloproteinase 7; Metalloproteinases; Sarcoidosis.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.Am J Respir Crit Care Med. 2016 Nov 15;194(10):1242-1251. doi: 10.1164/rccm.201505-0862OC. Am J Respir Crit Care Med. 2016. PMID: 27149370 Free PMC article.
-
MMP-7 and fcDNA serum levels in early NSCLC and idiopathic interstitial pneumonia: preliminary study.Int J Mol Sci. 2013 Dec 11;14(12):24097-112. doi: 10.3390/ijms141224097. Int J Mol Sci. 2013. PMID: 24336111 Free PMC article.
-
S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.Respir Med. 2012 Apr;106(4):571-80. doi: 10.1016/j.rmed.2011.12.010. Epub 2011 Dec 30. Respir Med. 2012. PMID: 22209187
-
[Idiopathic interstitial pneumonias in 2016].Rev Pneumol Clin. 2017 Feb;73(1):13-26. doi: 10.1016/j.pneumo.2016.09.001. Epub 2016 Oct 25. Rev Pneumol Clin. 2017. PMID: 27789161 Review. French.
-
Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?Chron Respir Dis. 2011;8(1):53-82. doi: 10.1177/1479972310393758. Chron Respir Dis. 2011. PMID: 21339375 Review.
Cited by
-
MMP-1 promoter polymorphism is associated with risk of radiation-induced lung injury in lung cancer patients treated with radiotherapy.Oncotarget. 2016 Oct 25;7(43):70175-70184. doi: 10.18632/oncotarget.12164. Oncotarget. 2016. PMID: 27659527 Free PMC article.
-
Diagnosis of Fibrotic Hypersensitivity Pneumonitis: Is There a Role for Biomarkers?Life (Basel). 2023 Feb 17;13(2):565. doi: 10.3390/life13020565. Life (Basel). 2023. PMID: 36836922 Free PMC article. Review.
-
Krebs von den Lungen-6 levels in untreated idiopathic pulmonary fibrosis.Clin Respir J. 2022 Mar;16(3):234-243. doi: 10.1111/crj.13475. Epub 2022 Jan 26. Clin Respir J. 2022. PMID: 35081277 Free PMC article.
-
Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions.Int J Mol Sci. 2021 Jun 10;22(12):6255. doi: 10.3390/ijms22126255. Int J Mol Sci. 2021. PMID: 34200784 Free PMC article. Review.
-
Serial Measurements of Circulating KL-6, SP-D, MMP-7, CA19-9, CA-125, CCL18, and Periostin in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Therapy: An Exploratory Study.J Clin Med. 2021 Aug 28;10(17):3864. doi: 10.3390/jcm10173864. J Clin Med. 2021. PMID: 34501312 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous